Another solution in some cases is to change a person's environment, relationships, job, etc... Some depression can be relieved by changing ones worldview or other purely psychological interventions.
In short, the notion of objective physical measures indicating specific conditions is not possible in most cases.
SSRIs are used to increase serotonin levels, but they dont even use a serotonin test to diagnose. I have my suspicion that there's not a strong correlation.
https://en.wikipedia.org/wiki/Functional_magnetic_resonance_...
One way to measure objectively is to look at whether someone is employable and maintains employment. But that is far too low resolution and non specific. People change their mood during a day and from one day to a next, and there must be physical correlates in principle.
There is a huge human cost to the fact that nobody knows what they are doing, because they cannot relate treatment to anything objective. Sometimes a drug seems to be not working well after several years, and the dosage is raised, and all the while the side effect of the drug is what's causing the problem, so it gets worse the higher the dosage goes. In the mean time, that person becomes unable to work, and is caught in a series of catch-22s.
We know that there is never going to be a straightforward genetic test for mental illness because plenty of studies have been done on identical twins, so it is clear there is no simple mutation out there to test for.
It is possible that there are metabolic abnormalities that show up in cerebrospinal fluid and not in blood tests. Assuming that because we use SSRIs we should therefore test serotonin is quite contrary to what I am suggesting.
It should be treated as axiomatic that there is a physical basis for variations in mood and cognitive function, and we need to be able to objectively quantify it. That's not simple to work out, but just because it's difficult doesn't make it less essential. Making up vague stories about causes is what's simplistic and does not help produce better treatments.
The main problem with current diagnostic tests is that they give equal weight to a wide range of symptoms (sleeping too much, not eating enough, feeling hopeless about the future, wanting to kill yourself) that may have wildly different importance to the patient. A treatment can look good in clinical trials without necessarily having a big impact on a patient's quality of life.
A biological test could be a retrograde step if it doesn't strongly correlate with the subjective hardships of depression.
But at this point, I look back and see the most important thing they ever funded was some of the early development of optogenetics. So I'm coming to believe that basic tools and measurement should get most of the available funding.
I think there's a lot of research directed at trying things at random that is just wasted. Any IT geek surely knows the difference between trying to debug something by flailing around with random theories and really buckling down and analyzing it. The latter seems slower, but it's the only way you make progress at all.
Agreeing on a standard red line for treatment - when mood changes merit intervention, is a different topic, and a long one, weighing risks, the profound corruption of modern medical studies, etc.